Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA

Toxicology and Applied Pharmacology

Volumn 141, Issue 2, 1996, Pages 532-539

  Farid, Ramy S ^a,b   Bianchi, Marco E ^a,c   Falciola, Luca ^a,c   Engelsberg, Beatrice N ^a   Billings, Paul C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; NONHISTONE PROTEIN;

ARTICLE; DNA DAMAGE; NONHUMAN; PROTEIN BINDING;

EID: 0030458879     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0319     Document Type: Article

References (29)

1. Baxter, J. D., and Funder, J. W. (1979). Hormone receptors. N. Eng. J. Med. 301, 1149-1161.
2. +. Biophys. Chem. 35, 179-188.
3. Bianchi, M. E., Falciola, L., Ferrari, S., and Lilley, D. M. J. (1992). The DNA binding site of HMG1 is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J. 11, 1055-1063.
4. Billings, P. C., Davis, R. J., Engelsberg, B. N., Skov, K. A., and Hughes, E. N. (1992). Characterization of high mobility group protein binding to cisplatin-damaged DNA. Biochem. Biophys. Res. Commun. 188, 1286-1294.
5. Bustin, M., Lehn, D. A., and Landsman, D. (1990). Structural features of the HMG chromosomal proteins and their genes. Biochem. Biophys. Acta 1049, 231-243.
6. Chow, C. S., Whitehead, J. P., and Lippard, S. J. (1994). HMG domain proteins induce sharp bends in cisplatin-modified DNA. Biochemistry 33, 15,124-15,130.
7. Chow, C. S., Barnes, C. M., and Lippard, S. J. (1995). A single HMG domain in high mobility group 1 protein binds to DNAs as small as 20 base pairs containg the major cisplatin adduct. Biochemistry 34, 2956-2964.
8. Chu, G. (1994). Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J. Biol. Chem. 269, 787-790.
9. Falciola, L., Murchie, A. I. M., Lilley, D. M. J., and Bianchi, M. E. (1994). Mutational analysis of the DNA binding domain A of chromosomal protein HMG1. Nucleic Acids Res. 22, 285-292.
10. Grosschedl, R., Giese, K., and Pagel, J. (1994). HMG domain proteins: Architectural elements in the assembly of nucleoprotein structures. Trends Genet. 10, 94-100.
11. Hughes, E. N., Engelsberg, B. N., and Billings, P. C. (1992). Purification of nuclear proteins that bind to cisplatin-damaged DNA: Identity with high mobility group proteins 1 and 2. J. Biol. Chem. 267, 13,520-13,527.
12. Jantzen, H. M., Admon, A., Bell, S. P., and Tjian, R. (1990). Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG Proteins. Nature 344, 830-836.
13. King, C. Y., and Weiss, M. (1993). The SRY high-mobility-group box recognizes DNA by partial intercalation in the minor groove: A topological mechanism of sequence specificity. Proc. Natl. Acad. Sci. USA 90, 11,990-11,994.
14. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of bacteriophage T4. Nature 227, 680-685.
15. Landsman, D., and Bustin, M. (1993). A signature for the HMG-1 Box DNA-binding proteins. BioEssays 15, 539-546.
16. Lawrence, D. L., Engelsberg, B. N., Farid, R. S., Hughes, E. N., and Billings, P. C. (1993). Localization of the binding region of high mobility group protein 2 to cisplatin-damaged DNA. J. Biol. Chem. 268, 23,940-23,945.
17. Locker, D., Decoville, M., Maurizot, J. C., Bianchi, M. E., and Leng, M. (1995). Interaction between cisplatin-modified DNA and the HMG boxes of HMG1: Dnase 1 footprinting and circular dichroism. J. Mol. Biol. 246, 243-247.
18. Pil, P. M., and Lippard, S. J. (1992). Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 256, 234-237.
19. Read, C. M., Cary, P. D., Crane-Robinson, C., Driscoll, P. C., and Norman, D. G. (1993). Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Res. 21, 3427-3436.
20. Read, C. M., Cary, P. D., Crane-Robinson, C., Driscoll, P.C., Carrillo, M. O. M., and Norman, D. G. (1995). The structure of the HMG box and its interaction with DNA. In Nucleic Acids and Molecular Biology (F. Eckstein and D. M. J. Lilley, Eds.), Vol. 9, pp. 222-250. Springer-Verlag, Berlin.
21. Schagger, H., and Jagow, C. V. (1987). Tricine-sodium dodecyl sulfate polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368-379.
22. Sinclair, A. H., Berta, P., Palmer, M. S., Hawkins, J. R., Griffiths, B. L., Smith, M. J., Foster, J. W., Frischauf, A. M., Lovell, B. R., and Goodfellow, P. N. (1990). A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346, 240-244.
23. Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., and Lippard, S. J. (1995). Crystal structure of double stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377, 649-652.
24. Travis, A., Amsterdam, A., Belanger, C., and Grosschedl, R. (1991). LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function [corrected; published erratum appears in Genes Dev. (1991) 5, following 1113] Genes Dev. 5, 880-894.
25. Treiber, D. K., Zhai, X. Q., Jantzen, H. M., and Essigmann, J. M. (1994). Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). Proc. Natl. Acad. Sci. USA 91, 5672-5676.
26. van de Wetering, M., and Clevers, H. (1992). Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson and Crick double helix. EMBO J. 11, 3039-3044.
27. Weir, H. M., Kraulis, P. J., Hill, C. S., Raine, A. R. C., Laue, E. D., and Thomas, J. O. (1993). Structure of the HMG box motif in the B-domain of HMG1. EMBO J. 12, 1311-1319.
28. Werner, M. H., Gronenborn, A. M., and Clore, G. M. (1996). Intercalation, DNA kinking and the control of transcription. Science 271, 778-784.
29. Werner, M. H., Huth, J. R., Gronenborn, A. M., and Clore, G. M. (1995). Molecular basis of human 46X, Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 81, 705-714.